Located in Provincial Chemical Industry Park, Jiande Railway New District, Zhejiang province, Allsino Pharmaceutical Co., LTD. (stock code 688076) was established in May 2004 covering an area of 146 Mu and committed to research and development and manufacturing of RSMs GMP intermediates and APIs. Products are mainly exported to the United States, Europe, Japan and other developed countries and regions.

We have 650+ employees (355 college degree and above, including 179 bachelors, 33 masters and 8 PhDs. Through independent research and development and international technical cooperation, Allsino has developed hundreds of projects relating to the therapeutic areas of anti-cancer, antidepressant, anti-hepatitis and some of the projects have been commercialized. At present, we holds 18 patents and 7 utility model patents. Allsino has established long-term business partnerships with many international pharmaceutical companies such as Gilead, Incyte and etc.

Qualified by ISO9001,ISO14001,ISO45001. In 2022, Allsino obtained the drug production license of API Agomelatine;In June 2023, it passed the GMP evaluation of NMPA . we’re national high-tech enterprise, a science and technology enterprise in Zhejiang Province, and a key industrial enterprise in Jiande City.